WSO879652 Supplemental Material - Supplemental material for Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study

Campbell, Bruce CV; Mitchell, Peter J; Churilov, Leonid; Yassi, Nawaf; Kleinig, Timothy J; Yan, Bernard; Thijs, Vincent; Desmond, Patricia M; Parsons, Mark W; Donnan, Geoffrey A; Davis, Stephen M

doi:10.25384/SAGE.9948833.v1

WSO879652_Supplemental_Material.pdf (185.33 kB)

WSO879652 Supplemental Material - Supplemental material for Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study

journal contribution

posted on 2019-10-08, 12:06 authored by Bruce CV Campbell, Peter J Mitchell, Leonid Churilov, Nawaf Yassi, Timothy J Kleinig, Bernard Yan, Vincent Thijs, Patricia M Desmond, Mark W Parsons, Geoffrey A Donnan, Stephen M Davis

Supplemental material, WSO879652 Supplemental Material for Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study by Bruce CV Campbell, Peter J Mitchell, Leonid Churilov, Nawaf Yassi, Timothy J Kleinig, Bernard Yan, Vincent Thijs, Patricia M Desmond, Mark W Parsons, Geoffrey A Donnan and Stephen M Davis in International Journal of Stroke